| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | 219395 | 002 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2026/06/03 | -- | SPECGX LLC | Prescription |
| TOFACITINIB CITRATE | 219530 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2026/06/03 | -- | MACLEODS PHARMS LTD | Prescription |
| TOFACITINIB CITRATE | 219530 | 002 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2026/06/03 | -- | MACLEODS PHARMS LTD | Prescription |
| TOFACITINIB CITRATE | 220137 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2026/06/03 | -- | SOMERSET THERAPS LLC | Prescription |
| TOFACITINIB CITRATE | 220137 | 002 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2026/06/03 | -- | SOMERSET THERAPS LLC | Prescription |
| TOFACITINIB CITRATE | 220458 | 001 | ANDA | TOFACITINIB CITRATE | TABLET, EXTENDED RELEASE;ORAL | EQ 11MG BASE | No | No | 2026/06/03 | -- | APOTEX | Prescription |
| TOFACITINIB CITRATE | 220458 | 001 | ANDA | TOFACITINIB CITRATE | TABLET, EXTENDED RELEASE;ORAL | EQ 11MG BASE | No | No | 2026/06/03 (TA) | -- | APOTEX | Prescription |
| TOFACITINIB CITRATE | 209829 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2026/06/05 | 2023/03/13 | ZYDUS PHARMS | Prescription |
| TOFACITINIB CITRATE | 209829 | 002 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2026/06/05 | -- | ZYDUS PHARMS | Prescription |